Caraco Denied Quick Win On Prandin IP Misuse Claim

By Abigail Rubenstein · February 25, 2011, 3:08 PM EST

A federal judge in Michigan on Thursday refused to analyze Caraco Pharmaceutical Laboratories Ltd.'s contention that Novo Nordisk A/S misused its patent for the diabetes drug Prandin, finding the matter inappropriate...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum Opinion & Order

Case Information

Case Title

Novo Nordisk A/S et al v. Caraco Pharmaceutical Laboratories, Limited

Case Number

Court

Michigan Eastern

Nature of Suit

Patent

Date Filed

June 09, 2005

Recent Articles By Abigail

June 24, 2015
Chinese Medical Equipment Lessor Seeks $546M In HK IPO
May 02, 2014
NLRB Strikes Down Nursing Home's Off-Duty Access Policy
April 21, 2014
CVS Blasts EEOC Suit Over 'Run Of The Mill' Contract Terms
April 02, 2014
NLRB Finds Hospital's Rule Banning Negativity Unlawful
March 14, 2014
Novant Health Sued Over Retirement Plan Fees
January 28, 2014
Colo. High Court To Decide Medical Marijuana Firing Suit
January 22, 2014
EEOC Sues Genesis For Refusing To Hire Deaf Worker
January 21, 2014
Justices Hear Arguments Over Mandatory Union Fees
December 18, 2013
EEOC Settles Claims Of Scientology Forced On Health Workers
December 04, 2013
CVS Workers Denied Class Cert. In Calif. Wage Action